Interaction of astemizole, an H1 receptor antagonist, with conventional antiepileptic drugs in mice

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 1, 2003, Pages 169-178

  Świa̧der, Mariusz ^a   Wielosz, Marian ^a   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Astemizole; Drug interactions; Electroshock maximal; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; ASTEMIZOLE; CARBAMAZEPINE; HISTAMINE H1 RECEPTOR ANTAGONIST; PHENOBARBITAL; PHENYTOIN; VALPROATE MAGNESIUM; HISTAMINE H1 RECEPTOR;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG EFFICACY; ELECTRIC SHOCK; FUNCTION TEST; IMMUNOFLUORESCENCE; LETHAL DOSE; LONG TERM MEMORY; LOW DRUG DOSE; MALE; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; ANIMAL; AVOIDANCE BEHAVIOR; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG INTERACTION; METABOLISM; PHYSIOLOGY; SEIZURE;

ANIMALIA;

ANIMALS; ANTICONVULSANTS; ASTEMIZOLE; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HISTAMINE H1 ANTAGONISTS; MALE; MICE; RECEPTORS, HISTAMINE H1; SEIZURES;

EID: 1642323714     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00212-0     Document Type: Article

References (39)

1. Awouters F.H.L., Niemegeers C.J.E., Janssen P.A.J. Pharmacology of the specific histamine H1-antagonist astemizole. Arzneim.-Forsch. 33:1983;3381-3388.
2. Boissier J.-R., Tardy J., Diverres J.-C. Une nouvelle methode simple pour explorer l'action 'tranquilisante': Le test de la cheminee. Med. Exp. 3:1960;81-84.
3. Borowicz K.K., Kamiński R., Gasior M., Kleinrok Z., Czuczwar S.J. Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur. Neuropsychopharmacol. 9:1999;185-190.
4. Borowicz K.K., Świader M., Kamiński R., Kuźniar H., Kleinrok Z., Czuczwar S.J. Two essential amino acids, L-lysine and L-histidine, in five types of experimental seizures. Pol. J. Pharmacol. 52:2000;345-352.
5. Churchull J.A., Gammon G.D. The effect of antihistaminic drugs on convulsive seizures. J. Am. Med. Assoc. 141:1949;18-21.
6. Czuczwar S.J., Janusz W., Szczepanik B., Wamil A., Kleinrok Z. Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci. Res. 6:1989;470-474.
7. Czuczwar S.J., Gasior M., Janusz W., Szczepanik B., Wlodarczyk D., Kleinrok Z. Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia. 31(3):1990;318-323.
8. Deckers C.L.P., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H.et al. Selection of antiepileptic drug polytherapy based on mechanism of action: the evidence reviewed. Epilepsia. 41:2000;1364-1374.
9. Duch D.S., Bowers S.W., Nichol C.A. Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyltransferase. Biochem. Pharmacol. 27:1978;1507-1509.
10. Duch D.S., Edelstein M.P., Nichol C.A. Inhibition of histamine- metabolizing enzymes and elevation of histamine levels in tissues by lipid-soluble anticancer folate antagonists. Mol. Pharmacol. 18:1980;100-104.
11. Dux E., Temesvári P., Szedahelyi P., Nagy A., Kovacs J., Joó F. Protective effect of antihistamines on cerebral oedema induced by experimental pneumothorax in newborn piglets. Neuroscience. 22:1987;317-321.
12. Fairbairn S., Sturman G. The influence of central histaminergic modification on the susceptibility of mice to chemically-induced seizures. [abstract] Br. J. Pharmacol. 97:1989;317. [suppl.].
13. Gasior M., Borowicz K., Buszewicz G., Kleinrok Z., Czuczwar S.J. Anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice during chronic treatment with caffeine and caffeine discontinuation. Epilepsia. 37(3):1996;262-268.
14. Gerald M.C., Richter N.A. Studies on the effects of histaminergic agents on seizure susceptibility in mice. Psychopharmacologia. 46:1976;277-282.
15. Kamei C., Ishizawa K., Kakinoki H., Fukunaga M. Histaminergic mechanisms in amygdaloid-kindled seizures in rats. Epilepsy Res. 30:1998;187-194.
16. Kamei C., Ohuchi M., Sugimoto Y., Okuma C. Mechanism responsible for epileptogenic activity by first-generation H1-antagonists in rats. Brain Res. 887:2000;183-186.
17. Leurs R., Smit M.J., Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 66:1995;413-463.
18. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
19. Malmberg-Aiello P., Ipponi A., Bartolini A., Schunack W. Antiamnesic effect of metoprine and of selective histamine H(1) receptor agonists in a modified mouse passive avoidance test. Neurosci. Lett. 288:2000;1-4.
20. Nicholson A.N., Pascoe P.A., Turner C., Ganellin C.R., Casay A.F., Mercer A.D. Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br. J. Pharmacol. 104:1991;270-276.
21. Nowak J.Z. Effects of histamine H1- and H2-receptor antagonists on dopamine, noradrenaline and serotonin systems in rat brain. Pol. J. Pharmacol. Pharm. 32:1980;451-461.
22. Onodera K., Tuomisto L., Tacke U., Airaksinen M. Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats. Methods Find. Exp. Clin. Pharmacol. 14:1992;13-16.
23. Philippu A., Bald M., Kraus A., Dietl H. In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hypothalamus. Naunyn-Schmiedeberg's Arch. Pharmacol. 326:1984;116-123.
24. Scherkl R., Hashem A., Frey H.H. Importance of histamine seizure susceptibility. Timmerman H., van der Groot H. New perspectives in histamine research. 1991;85-89 Birkhäuser, Basel.
25. Scherkl R., Hashem A., Frey H. Histamine in brain - its role in regulation of seizure susceptibility. Epilepsy Res. 10:1991;111-118.
26. Schwartz J.F., Patterson J.H. Toxic encephalopathy related to antihistamine-barbiturate antiemetic medication. Am. J. Dis. Child. 32:1978;37-39.
27. Schwartz J.C., Garbarg M., Quach T.T. Histamine receptors in brain, a target for tricyclic antidepressants. Trends Pharmacol. Sci. 2:1981;122-125.
28. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiol. Rev. 71:1991;1-51.
29. Shishido S., Oishi R., Saeki K. In vivo effect of some histamine H1-receptor antagonists on monoamine metabolism in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 343:1991;185-189.
30. Świader M., Kalisz A., Poraebiak J., Kleinrok Z., Czuczwar S.J. Influence of antazoline on the anticonvulsant activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice. [abstract] Pol. J. Pharmacol. 51:1999;104.
31. Świader M., Chwalczuk K., Wielosz M., Czuczwar S.J. Influence of chronic treatment with H1 receptor antagonists on the anticonvulsant activity of antiepileptic drugs. Pol. J. Pharmacol. 53:2001;93-96.
32. Tuomisto L., Tacke U. Is histamine an anticonvulsive inhibitory transmitter? Neuropharmacology. 25:1986;955-958.
33. Tuomisto J., Tuomisto L. Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes. Med. Biol. 58:1980;33-37.
34. Venault P., Chapouthier P., de Carvallo L.P., Simiand J., Morre M., Dodd R.H.et al. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature. 321:1986;864-866.
35. Wada H., Inagaki N., Yamatodani A., Watanabe T. Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci. 14:1991;415-419.
36. Wada Y., Shiraishi J., Nakamura M., Koshino Y. Biphasic action of the histamine precursor L-histidine in the rat kindling model of epilepsy. Neurosci. Lett. 204:1996;205-208.
37. Wyngarden J.B., Seevers M.H. The toxic effects of antihistaminic drugs. J. Am. Med. Assoc. 145:1951;277-282.
38. Yokoyama H., Onodera K., Maeyama K., Yanai K., Iinuma K., Tuomisto L.et al. Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of α-fluoromethylhistidine and metoprine. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;40-45.
39. Yokoyama H., Onodera K., Iinuma K., Watanabe T. Proconvulsive effects of histamine H1-antagonists on electrically-induced seizure in developing mice. Psychopharmacology. 112:1993;199-203.